BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020; 26(16): 1901-1911 [PMID: 32390701 DOI: 10.3748/wjg.v26.i16.1901]
URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1901.htm
Number Citing Articles
1
Chencheng Xie, Dina Halegoua-DeMarzio. The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2020; 19(4): 420 doi: 10.1007/s11901-020-00547-5
2
Shuang Hu, Pan-pan Lian, Ying Hu, Xing-yu Zhu, Shao-wei Jiang, Qiang Ma, Liang-yun Li, Jun-fa Yang, Li Yang, Hai-yue Guo, Hong Zhou, Chen-chen Yang, Xiao-ming Meng, Jun Li, Hai-wen Li, Tao Xu, Huan Zhou. The Role of IL-35 in the Pathophysiological Processes of Liver DiseaseFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.569575
3
Sanja Stojsavljevic-Shapeski, Marko Duvnjak, Lucija Virovic-Jukic, Davor Hrabar, Lea Smircic Duvnjak. New Drugs on the Block—Emerging Treatments for Nonalcoholic SteatohepatitisJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00057
4
Ammar Salehi-sahlabadi, Samaneh Sadat, Sara Beigrezaei, Makan Pourmasomi, Awat Feizi, Reza Ghiasvand, Amir Hadi, Cain C. T. Clark, Maryam Miraghajani. Dietary patterns and risk of non-alcoholic fatty liver diseaseBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01612-z
5
Guo-Ming Dong, Hang Yu, Li-Bin Pan, Shu-Rong Ma, Hui Xu, Zheng-Wei Zhang, Pei Han, Jie Fu, Xin-Yu Yang, Adili Keranmu, Hai-Tao Niu, Jian-Dong Jiang, Yan Wang. Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut MicrobiotaMolecules 2021; 26(13): 3861 doi: 10.3390/molecules26133861
6
Manisha Gupta, Pawan Krishan, Amarjot Kaur, Sandeep Arora, Nirupma Trehanpati, Thakur Gurjeet Singh, Onkar Bedi. Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLDInflammation Research 2021; 70(7): 765 doi: 10.1007/s00011-021-01480-z
7
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li, Lin Wang. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanismsChemico-Biological Interactions 2020; 330: 109199 doi: 10.1016/j.cbi.2020.109199
8
Pau Vancells Lujan, Esther Viñas Esmel, Emilio Sacanella Meseguer. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its DevelopmentNutrients 2021; 13(5): 1442 doi: 10.3390/nu13051442
9
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic DiseasesJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
10
Mona Mohamed Taha, Yasser M. Aneis, Heba Mohamed Mohamady, Alrasheedy S. A., Shereen Hamed Elsayed, Wan-Long Chuang. Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trialPLOS ONE 2021; 16(4): e0250337 doi: 10.1371/journal.pone.0250337